Overview

The Global Anthrax Vaccines Market growing at a CAGR of 7.4% during the forecast period (2024-2031)

Anthrax is transmitted through contact with animals or contaminated animal products, but it is not spread from person to person. It has the potential to be used as a biological weapon against U.S. military personnel during combat.

Request for free sample:https://www.datamintelligence.com/download-sample/anthrax-vaccines-market

Market Growth Trends

The Rising Clinical Trials for Anthrax Vaccines are Expected to Drive Market Growth.

On April 1, 2021, Altimmune, Inc., a clinical-stage biopharmaceutical company, announced clinical data on its NasoShield intranasal anthrax vaccine candidate. The Phase 1b trial assessed the safety and immunogenicity of one- and two-dose regimens of NasoShield in healthy volunteers. This clinical trial was conducted in collaboration with the Biomedical Advanced Research and Development Authority (BARDA).

Get your customized report @https://www.datamintelligence.com/customize/anthrax-vaccines-market

Market is segmented

By Product Type:  Cell-Free Vaccines, Live Attenuated Vaccines

By Application:  Human Use, Animal User

By End User:  Hospitals, Clinics, Vaccination Centers

By Region:  North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Market Key Players

• Merck & Co., Inc.
• Emergent Bio-Solutions
• Zoetis Inc.
• PharmaAthene Inc.
• Biogenesis Bago Inc.
• Porton Biopharma Inc.
• Colorado Serum
• Sanofi SA
• Vecol SA
• Panacea Biotec

Related Reports

Cancer Vaccines Market

Animal Vaccine Market  

Contact Us:

Company Name: DataM Intelligence

Email: info@datamintelligence.com

Contact Person: Sai. K

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About DataM Intelligence:

DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. At DataM Intelligence, we leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across